Chamber and committees

I refer to member to the answer to question S6W-05124 on 10 January 2022. All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

I refer the member to the answer to question S6W-04154 on 17 November 2021.

In relation to other technologies that could reduce pressure on the pharmacy sector, community pharmacies have had access to NHS Near Me since 2020. This offers an additional communication tool for use with healthcare professionals and patients. Pharmacists also have access to the Emergency Care Summary and we are working with Health Boards to ensure pharmacists have appropriate access to patient information through the Clinical Portal. The ePharmacy Programme continues to oversee and develop technology used in community pharmacies to support the provision of NHS pharmaceutical care services.

All answers to written parliamentary questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.

All patient conveying vehicles including paramedic response units carry defibrillators and staff are trained to use them. Community First responder vehicles also carry defibrillators, and the Scottish Ambulance Service has access to a system which is used to direct members of public to the closest registered defibrillator.

I refer the member to the answer to question S6W-05371 on 10 January 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

I refer the member to the answer to question S6W-05371 on 10 January 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

As you are aware, our NHS is currently facing the most difficult circumstances in its history due to the ongoing COVID-19 pandemic. This is exacerbated at present due to the potential risk posed by the Omicron variant to our healthcare system. This means Health Boards are having to make very difficult decisions about prioritising care, and I know this has an impact on everyone who is waiting for support for their health at this time.

We recognise that this includes people experiencing chronic pain, and that is why we are providing funding to enhance the capacity of pain management care through the Chronic Pain Winter Support Fund. We will shortly announce the outcome of this funding call. The projects we fund will boost the support available for people with chronic pain at the national and local level to help them maintain their health and wellbeing over the months ahead.

I refer the member to the answer to question S6W-05156 on 10 January 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

I refer the member to the answer to question S6W-05035 on 3 December 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The Scottish Government does not hold information on temporary closures of community pharmacies or the possible cost incurred by the NHS.

The provision of community pharmacy pharmaceutical care services are the responsibility of territorial Health Boards as set out in the National Health Service (Pharmaceutical Services) (Scotland) Regulations 2009. Any challenges faced by community pharmacies in ensuring the safe and effective dispensing of treatments should be discussed with the local Health Board.

Following a successful three year pilot, in 2013 the four nations agreed to a 10 year grant to support those affected by the thalidomide drug. Over the last nine years the Scottish Government has issued a total of £11.512 million to the Thalidomide Trust, for distribution to Scottish survivors. A further £1.636 Million is projected for the final year (2022-23), bringing total funding to £13.15 million.